1985-91 Corvette Muffler Eliminator

Un nuovo topico per la psoriasi: bimosiamose

The German Revotar Biopharmaceuticals AG has started a trial Phase II of its Bimosiamose cream 5%. The cream was safe and well tolerated by study Phase I. The

Bimosiamose is a new potent synthetic inhibitor of all selectins (P, E, L), molecules that are fundamental in nell'attachment leukocyte rolling and migration during vascular endothelium at sites of inflammation.

Bibliography:
Bimosiamose AND psoriasis on PubMed

Ladies Housecoats In Canada

Un nuovo indice per misurare la QoL

E 'trial started a to create and validate a new index called CQOL (Chronic Quality of Life) that explores habits, career and life choices of psoriasis patients.
The hypothesis of the authors is that patients with the diagnosis (and therapy) are made at a young age may have a worse quality of life in the long run.